Enrollment is open for participants in a nationwide National Institutes of Health (NIH)-funded clinical trial testing a noninvasive device designed to help alleviate symptoms of carpal tunnel syndrome (CTS).
People diagnosed with carpal tunnel syndrome in the past 12 months and have had the diagnosis confirmed via a nerve conduction study may be eligible to join the study.
The study, which will be conducted remotely, requires that participants wear the study device on the wrist daily for 2 months, followed by 3 months of online follow-up. Participants will also be required to fill out a daily usage log and complete periodic online surveys to evaluate changes in CTS symptoms.
The trial is limited to 100 participants, and those who participate will be compensated at the trial’s completion, according to PPS, in a media release.
For more information, visit PPS.
[Source(s): PPS, PRWeb]